We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about retinoblastoma, a rare eye cancer affecting children. Understand its causes, symptoms like a white pupil and crossed eyes, diagnosis, and treatment options including chemotherapy and surgery. Discover how early detection can prevent blindness and preserve vision.

Understanding Retinoblastoma: A Rare Eye Cancer in Children Retinoblastoma is a rare but serious form of eye cancer that primarily affects young children, typically those under the age of 5. It originates in the retina, the light-sensitive tissue at the back of the eye responsible for converting light into signals that the brain interprets as images. While rare, understanding its causes, symptoms, and potential impact on vision is crucial for early detection and effective treatment. What is Retinoblastoma? Retinoblastoma begins when cells in the retina undergo abnormal changes and grow uncontrollably, forming a tumor. This condition accounts for a small percentage of childhood cancers, but its potential to cause blindness and, in severe cases, be life-threatening, makes it a significant concern. Globally, about 8,000 children are diagnosed with retinoblastoma each year. While it is most common in very young children, it can affect individuals of all ages. Causes of Retinoblastoma The primary cause of retinoblastoma is a mutation in the RB1 gene. Each person has two copies of this gene, inherited from their parents. For retinoblastoma to develop, both copies of the RB1 gene in a single retinal cell must be altered or mutated. These mutations can occur in two ways: Inherited Mutations: In about 90% of cases, the mutation is inherited from a parent. Even if the parent does not have retinoblastoma, they can be carriers of the mutated gene and pass it on. Children with an inherited mutation have a higher risk of developing the cancer in both eyes (bilateral retinoblastoma). Spontaneous Mutations: In about 10% of cases, the mutations occur spontaneously in the retinal cells after conception, without being inherited. These cases are often unilateral (affecting only one eye). It's important to note that fewer than 3% of retinoblastoma cases occur without any mutation in the RB1 gene, and these typically present in infants before they are 6 months old. Symptoms of Retinoblastoma Early detection is key to successful treatment. Parents and caregivers should be vigilant for the following signs and symptoms: Leukocoria (White Pupil): This is the most common sign. When light is shone into the eye, the pupil may appear white or yellowish instead of the usual red reflex. This can be noticed in photographs where the flash reflects off the tumor. Strabismus (Crossed Eyes): One or both eyes may turn inward, outward, upward, or downward. Vision Problems: A child might squint, blink excessively, or hold objects very close to their face to see. They may also appear to have difficulty focusing. Eye Redness, Pain, or Swelling: In some cases, the eye may become red, painful, or swollen, though this is less common in the early stages. Poor Vision: A child might seem to have significantly reduced vision or may bump into objects more frequently. If you notice any of these symptoms in your child, it is essential to consult a doctor immediately. Diagnosis of Retinoblastoma Diagnosing retinoblastoma involves a comprehensive eye examination by an ophthalmologist, preferably one specializing in pediatric eye conditions. The diagnostic process may include: Ophthalmoscopy: The doctor will examine the inside of the eye using a special instrument called an ophthalmoscope. This may be done after dilating the pupils with eye drops to get a clearer view of the retina. Imaging Tests: Techniques like ultrasound, CT scans, or MRI scans may be used to confirm the presence of a tumor, assess its size and location, and determine if it has spread within the eye or to surrounding tissues. Genetic Testing: In cases of suspected inherited retinoblastoma, genetic testing may be recommended for the child and their family members to identify the RB1 gene mutation. Treatment Options for Retinoblastoma The treatment approach for retinoblastoma depends on several factors, including the size and location of the tumor, whether it affects one or both eyes, and whether it has spread. The primary goals of treatment are to save the child's life, preserve the affected eye(s) if possible, and maintain as much vision as possible. Common treatment modalities include: Chemotherapy: This involves using drugs to kill cancer cells. It can be administered intravenously (through a vein) or directly into the eye (intravitreal chemotherapy). Systemic chemotherapy is often used for larger tumors or when the cancer is in both eyes. Cryotherapy: This treatment uses extreme cold to freeze and destroy tumor cells. Laser Therapy (Thermotherapy): A laser is used to heat and destroy tumor cells. Brachytherapy: A small radioactive plaque is surgically placed directly on the eye, near the tumor, to deliver radiation. Enucleation (Surgery): In severe cases, especially when the tumor is large or has damaged the eye significantly, surgical removal of the eyeball (enucleation) may be necessary. If both eyes are affected, this could lead to complete blindness. It is vital to have open discussions with the medical team about the potential long-term effects of each treatment on vision. Can Retinoblastoma Cause Blindness? Yes, untreated or advanced retinoblastoma can lead to blindness. If the tumor grows large enough, it can obstruct vision by blocking light from reaching the retina or by damaging the retina itself. Furthermore, if the cancerous cells spread to other parts of the eye or optic nerve, vision loss can be more severe. Certain treatments, while life-saving, can also have implications for vision. For instance, laser therapy can sometimes cause scarring or damage to the delicate structures within the eye, potentially leading to vision impairment. In cases requiring enucleation of both
In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026